Undaria pinnatifida Fucoidan Enhances Gut Microbiome, Butyrate Production, and Exerts Anti-Inflammatory Effects in an In Vitro Short-Term SHIME® Coupled to a Caco-2/THP-1 Co-Culture Model
Marine Drugs · 2025
DOI: 10.3390/md23060242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Barbara C Wimmer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Marinova Pty Ltd., 249 Kennedy Drive, Cambridge, TAS 7170, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Polysaccharides, Undaria, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marinova Pty Ltd., 249 Kennedy Drive, Cambridge, TAS 7170, Australia, trial sponsor Marinova Pty Ltd..
Abstract (Originalsprache)
Fucoidans have demonstrated a wide range of bioactivities including immune modulation and benefits in gut health. To gain a deeper understanding on the effects of fucoidan from Undaria pinnatifida (UPF) on the colonic microbiome, the short-term Simulator of the Human Intestinal Microbial Ecosystem®, a validated in vitro gut model, was applied. Following a three-week intervention period on adult faecal samples from three healthy donors, microbial community activity of the colonic microbiota was assessed by quantifying short-chain fatty acids while composition was analysed utilising 16S-targeted Illumina sequencing. Metagenomic data were used to describe changes in community structure. To assess the secretion of cytokines, co-culture experiments using Caco-2 and THP1-Blue™ cells were performed. UPF supplementation over a three-week period had a profound butyrogenic effect while also enriching colonic microbial diversity, consistently stimulating saccharolytic genera, and reducing genera linked with potentially negative health effects in both regions of the colon. Mild immune modulatory effects of UPF were also observed. Colonic fermentation of UPF showed anti-inflammatory properties by inducing the secretion of the anti-inflammatory cytokines IL-6 and IL-10 in two out of three donors in the proximal and distal colon. In conclusion, UPF supplementation may provide significant gut health benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marinova Pty Ltd., 249 Kennedy Drive, Cambridge, TAS 7170, Australia.
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium.
- Center of Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9052 Ghent, Belgium.
ORCID-Profile: Corinna Dwan, Jelle De Medts, Chloë Rotsaert
Förderung
- Marinova Pty Ltd., 249 Kennedy Drive, Cambridge, TAS 7170, Australia
- trial sponsor Marinova Pty Ltd.
Zitieren
APA
Wimmer, B. C., Dwan, C., De Medts, J., Duysburgh, C., Rotsaert, C., & Marzorati, M. (2025). Undaria pinnatifida Fucoidan Enhances Gut Microbiome, Butyrate Production, and Exerts Anti-Inflammatory Effects in an In Vitro Short-Term SHIME® Coupled to a Caco-2/THP-1 Co-Culture Model. Marine Drugs. https://doi.org/10.3390/md23060242
Vancouver
Wimmer BC, Dwan C, De Medts J, Duysburgh C, Rotsaert C, Marzorati M. Undaria pinnatifida Fucoidan Enhances Gut Microbiome, Butyrate Production, and Exerts Anti-Inflammatory Effects in an In Vitro Short-Term SHIME® Coupled to a Caco-2/THP-1 Co-Culture Model. Marine Drugs. 2025. doi:10.3390/md23060242
BibTeX
@article{Wimmer2025,
author = {Wimmer, Barbara C and Dwan, Corinna and De Medts, Jelle and Duysburgh, Cindy and Rotsaert, Chloë and Marzorati, Massimo},
title = {Undaria pinnatifida Fucoidan Enhances Gut Microbiome, Butyrate Production, and Exerts Anti-Inflammatory Effects in an In Vitro Short-Term SHIME® Coupled to a Caco-2/THP-1 Co-Culture Model},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23060242}
}
EUVIMED